Jonathan Young Insider Trading $AKRO Akero Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan Young.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan Young. Jonathan Young is Chief Operating Officer in Akero Therapeutics, Inc. ($AKRO).
Jonathan Young in Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jonathan Young: Chief Operating Officer
Holdings: 167,065 shares
Latest Transaction: May 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan Young in Akero Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 30.56 | 3,055 | 93,361 | 167,065 | 170.1 K to 167.1 K (-1.80 %) |
| Feb 02 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 29.92 | 200 | 5,984 | 176,230 | 176.4 K to 176.2 K (-0.11 %) |
| Feb 02 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 29.19 | 2,855 | 83,337 | 176,430 | 179.3 K to 176.4 K (-1.59 %) |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 7,500 | 4,613 | 35,296 | |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Sell | S | 28.12 | 10,000 | 281,200 | 179,285 | 189.3 K to 179.3 K (-5.28 %) |
| Jan 11 2021 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 7,500 | 4,613 | 189,285 | 181.8 K to 189.3 K (+4.13 %) |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 6,082 | 3,740 | 94,268 | |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 5,035 | 3,097 | 42,796 | |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 6,082 | 3,740 | 183,600 | 177.5 K to 183.6 K (+3.43 %) |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 5,035 | 3,097 | 177,518 | 172.5 K to 177.5 K (+2.92 %) |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 6,082 | 3,740 | 94,268 | |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 5,035 | 3,097 | 42,796 | |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 6,082 | 3,740 | 183,600 | 177.5 K to 183.6 K (+3.43 %) |
| Mar 16 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 5,035 | 3,097 | 177,518 | 172.5 K to 177.5 K (+2.92 %) |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 21,286 | 13,091 | 100,350 | |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 17,621 | 10,837 | 47,831 | |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 21,286 | 13,091 | 232,483 | 211.2 K to 232.5 K (+10.08 %) |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 17,621 | 10,837 | 211,197 | 193.6 K to 211.2 K (+9.10 %) |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 21,286 | 13,091 | 100,350 | |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | M | 0.62 | 17,621 | 10,837 | 47,831 | |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 21,286 | 13,091 | 232,483 | 211.2 K to 232.5 K (+10.08 %) |
| Jan 10 2020 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | M | 0.62 | 17,621 | 10,837 | 211,197 | 193.6 K to 211.2 K (+9.10 %) |
| Dec 31 2019 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Buy | W | 0.00 | 667 | 0 | 193,576 | 192.9 K to 193.6 K (+0.35 %) |
| Dec 13 2019 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | A | 21.09 | 85,000 | 1,792,650 | 85,000 | |
| Dec 13 2019 | AKRO | Akero Therapeutics ... | Young Jonathan | Chief Operating Off ... | Option Exercise | A | 21.09 | 85,000 | 1,792,650 | 85,000 |
Page: 1